# Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)

> **NCT03163277** · PHASE4 · TERMINATED · sponsor: **Giovanni Di Perri** · enrollment: 38 (actual)

## Conditions studied

- Hiv
- Neurocognitive Dysfunction

## Interventions

- **DRUG:** emtricitabine, darunavir/cobicistat, maraviroc

## Key facts

- **NCT ID:** NCT03163277
- **Lead sponsor:** Giovanni Di Perri
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-15
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** Sloww accrual and COVID-19 related problems (impossible to perform LPs)
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163277, "Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03163277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*